Duncan Jason
SEC insider (Form 3/4/5 filer). CIK 0001741553. Officer at Neumora Therapeutics, Inc. (NMRA). 9 reported Form 4/5 transactions since Sep 2024; latest on Aug 20, 2026. Located in WATERTOWN, MA.
Companies Duncan Jason has filed insider reports for
- Neumora Therapeutics, Inc. (NMRA): Officer, See Remarks
Duncan Jason
CIK: 0001741553
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Neumora Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Aug 20, 2026NMRA
Neumora Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
375K shares- - Jan 8, 2026NMRA
Neumora Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
750K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
400K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
500K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
400K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
500K shares- - Feb 13, 2025NMRA
Neumora Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
500K shares- - Feb 13, 2025NMRA
Neumora Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
400K shares- - Feb 13, 2025NMRA
Neumora Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
400K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 20, 2026 | NMRA Neumora Therapeutics, Inc. | Award Stock Option (Right to Buy) | 375,000 | - | - | Direct |
| Jan 8, 2026 | NMRA Neumora Therapeutics, Inc. | Award Stock Option (Right to Buy) | 750,000 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Award Stock Option (Right to Buy) | 400,000 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Award Stock Option (Right to Buy) | 500,000 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 400,000 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 500,000 | - | - | Direct |
| Feb 13, 2025 | NMRA Neumora Therapeutics, Inc. | Award Stock Option (Right to Buy) | 500,000 | - | - | Direct |
| Feb 13, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 400,000 | - | - | Direct |
| Feb 13, 2025 | NMRA Neumora Therapeutics, Inc. | Award Stock Option (Right to Buy) | 400,000 | - | - | Direct |
1-9 of 9 transactions